| |
 |
|
Class Information
Number: 530/388.25
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. > Globulins > Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed > Monoclonal > Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) > Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a plasma protein, serum protein, or with fibrin.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625560 |
Humanized antibodies that recognize beta amyloid peptide |
Dec. 1, 2009 |
| 7622558 |
Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use |
Nov. 24, 2009 |
| 7608695 |
Substance with antithrombotic activity and method for detecting glycokallidin |
Oct. 27, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7589182 |
Anti-sulfotyrosine antibodies |
Sep. 15, 2009 |
| 7582296 |
Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
Sep. 1, 2009 |
| 7579000 |
Tissue factor targeted antibodies as anticoagulants |
Aug. 25, 2009 |
| 7579447 |
Antibodies against LLG polypeptides of the triacylglycerol lipase family |
Aug. 25, 2009 |
| 7575872 |
Antibody against von Willebrand factor cleaving enzyme and assay system using the same |
Aug. 18, 2009 |
| 7575747 |
A.beta. binding molecules |
Aug. 18, 2009 |
| 7553936 |
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions |
Jun. 30, 2009 |
| 7541149 |
Monoclonal antibody and assay for detecting PIIINP |
Jun. 2, 2009 |
| 7541160 |
ELISA for VEGF |
Jun. 2, 2009 |
| 7534580 |
PSP94 diagnostic reagents and assays |
May. 19, 2009 |
| 7531169 |
High affinity anti-human IgE antibodies |
May. 12, 2009 |
| 7517965 |
Non-neutralizing anti-aPC antibodies |
Apr. 14, 2009 |
| 7517524 |
Immunointeractive molecules |
Apr. 14, 2009 |
| 7514539 |
Epitope directed selection of antibodies to murine tissue factor |
Apr. 7, 2009 |
| 7449303 |
Use of JAG2 expression in diagnosis of plasma cell disorders |
Nov. 11, 2008 |
| 7438911 |
Antibody against human insulin-like growth factor |
Oct. 21, 2008 |
| 7435413 |
Anti-tissue factor antibodies with enhanced anticoagulant potency |
Oct. 14, 2008 |
| 7432356 |
Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
Oct. 7, 2008 |
| 7423128 |
Anti-properdin antibodies, and methods for making and using same |
Sep. 9, 2008 |
| 7390490 |
Uses of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine |
Jun. 24, 2008 |
| 7381802 |
Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
Jun. 3, 2008 |
| 7364735 |
Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
Apr. 29, 2008 |
| 7354585 |
Methods of treating coagulapathic or thrombotic disorders |
Apr. 8, 2008 |
| 7348412 |
Ouabain-specific monoclonal antibodies |
Mar. 25, 2008 |
| 7339035 |
Antibody recognizing GM1 ganglioside-bound amyloid .beta.-protein and DNA encoding the antibody |
Mar. 4, 2008 |
| 7329737 |
Antibodies that bind hK-1 |
Feb. 12, 2008 |
| 7311913 |
Methods of treating thrombotic diseases with von Willebrand factor specific antibodies |
Dec. 25, 2007 |
| 7297336 |
Factor IXa specific antibodies displaying factor VIIIa like activity |
Nov. 20, 2007 |
| 7291333 |
Blockade of protein C activation reduces microvascular surgical blood loss |
Nov. 6, 2007 |
| 7279158 |
Methods for the treatment of inflammatory joint disease |
Oct. 9, 2007 |
| 7279161 |
Factor IX/factor IXa activating antibodies and antibody derivatives |
Oct. 9, 2007 |
| 7273925 |
Methods and products for regulating lectin complement pathway associated complement activation |
Sep. 25, 2007 |
| 7258989 |
Carbohydrate deficient transferrin (CDT) -specific antibodies, their preparation and use |
Aug. 21, 2007 |
| 7250168 |
Tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
Jul. 31, 2007 |
| 7244580 |
Epsilon immunoglobulin chain derived peptides for induction of anti-IgE antibodies |
Jul. 17, 2007 |
| 7241578 |
Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit |
Jul. 10, 2007 |
| 7235643 |
Antibodies and methods for generating genetically altered antibodies with high affinity |
Jun. 26, 2007 |
| 7214785 |
Human-type anti-blood coagulation factor VIII antibody |
May. 8, 2007 |
| 7157085 |
Method for treating IgE-mediated disorders |
Jan. 2, 2007 |
| 7138116 |
Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody |
Nov. 21, 2006 |
| 7132510 |
Specific human antibodies for selective cancer therapy |
Nov. 7, 2006 |
| 7122324 |
Vitro methods for determining in vivo thrombotic events |
Oct. 17, 2006 |
| 7112327 |
Inhibition of complement activation |
Sep. 26, 2006 |
| 7098036 |
Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
Aug. 29, 2006 |
| 7083786 |
MASP-2, a complement-fixing enzyme, and uses for it |
Aug. 1, 2006 |
| 7067313 |
Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
Jun. 27, 2006 |
|
|
|
